Patients who received single intravenous dose of tocilizumab were also more likely to leave the hospital or be off ventilator within a month, despite double the risk of additional infection   Ann Arbor, MI, USA (July 13, 2020) — Critically ill COVID-19 patients who received a single dose of a drug that calms an
WEITERLESEN »

  Study shows engaged workers should dare to daydream   St. Louis, MO, USA (July 13, 2020) —  A wandering, daydreaming mind can spur creativity … wait, where was I? Oh, yes, two researchers from Washington University in St. Louis and another from Pontificia Universidad Católica in Chile found that daydreaming carries significant creative benefits, especially
WEITERLESEN »

  Leicestershire, UK (July 10, 2020) — The early and correct diagnosis of a cognitive impairment – such as dementia – is crucial as it allows interventions and treatments that may slow the progression of a patient’s symptoms to be quickly put in place. However, a new study by Loughborough University researcher Dr Christian Füllgrabe
WEITERLESEN »

The IVY Research Network has completed initial studies evaluating the epidemiology of COVID-19 in health care workers and patients. Nashville, Tennessee, USA (July 9, 2020) — Among 249 front-line health care workers who cared for COVID-19 patients during the first month of the pandemic in Tennessee, 8% tested positive for COVID-19 antibodies by serology testing,
WEITERLESEN »

AMSTERDAM, NETHERLANDS (July 9, 2020) — Teva Pharmaceutical Europe B.V. has presented results from a pooled analysis of three randomized, double-blind, placebo-controlled Phase 3 studies assessing AJOVY® ▼ (fremanezumab), indicated for the preventative treatment of migraine in adults, which demonstrate clinically significant reductions in headache and migraine-related disability in the majority of patients studied. The
WEITERLESEN »

Study sheds new insight into the brain mechanisms at work Albuquerque, NM, USA (July 9, 2020) — A deadly coronavirus pandemic, economic instability and civil unrest menace the mental well-being of millions. Understanding how, in vulnerable people, fear from such frightening events evolves into lifelong anxiety, is critical for healing. A University of New Mexico
WEITERLESEN »

    Tucson, Arizona, USA (July 8, 2020) — It’s intuitive and scientifically shown that wearing a face covering can help reduce the spread of the novel coronavirus that causes COVID-19. But not all masks are created equal, according to new University of Arizona-led research. Amanda Wilson, an environmental health sciences doctoral candidate in the
WEITERLESEN »

No difference in the level of satisfaction or function between the two methods of delivery Hamilton, ON, Canada (July 8, 2020) – Cognitive behavioural therapy delivered electronically to treat people with depression is more effective than face to face, suggests an evidence review led by McMaster University. Based on randomized control trials, the systematic review
WEITERLESEN »

Liverpool, UK (July 8, 2020) — Cases of brain complications linked to COVID-19 are occurring across the globe, a new review by University of Liverpool researchers has shown. Published in The Lancet Neurology, the study found that strokes, delirium and other neurological complications are reported from most countries where there have been large outbreaks of
WEITERLESEN »

  Boston, MA, USA (July 7, 2020) — Amid news that the United States has bought up virtually the entire global supply of remdesivir, a new Boston University School of Public Health (BUSPH) study outlines how the drug could save lives in countries with less hospital capacity, such as South Africa, where COVID-19 is beginning
WEITERLESEN »

The discovery of two new biomarkers has the potential to predict key underlying causes of preeclampsia and could lead to the early diagnosis Sydney, Australia (July 3, 2020) — Preeclampsia is a devastating disorder that occurs very suddenly in the second half of pregnancy and causes severe health problems for both mother and baby. Preeclampsia
WEITERLESEN »

  Lausanne, Switzerland (July, 2020) — Teenagers who prefer to stay up late and wake later in the morning are more likely to suffer with asthma and allergies compared to those who sleep and wake earlier, according to a study published inERJ Open Research. [1] Asthma symptoms are known to be strongly linked to the
WEITERLESEN »

Why do more women have Alzheimer’s than men? It’s not just from living longer MINNEAPOLIS, USA (June 24, 2020) — Middle-aged women are more likely than men to have changes in the brain related to Alzheimer’s disease, as detected by imaging, even when there are no differences in thinking and memory. This may be associated
WEITERLESEN »

Oxford, UK (June 24, 2020) — Research presents new evidence which strengthens the plausibility that treatment with the novel anti-osteoporotic medicine, romosozumab, may lead to excess cardiovascular complications Research presents new evidence which strengthens the plausibility that treatment with the novel anti-osteoporotic medicine, romosozumab, may lead to excess cardiovascular complications. Writing in Science Translational Medicine,
WEITERLESEN »

Washington, DC, USA (June 24, 2020) – Both symptomatic and asymptomatic COVID-19 patients have the capability of contaminating their surroundings, according to a new study published in mSphere, an open-access journal of the American Society for Microbiology. The data, which comes from a patient study conducted in China, demonstrates the importance of environmental cleaning in
WEITERLESEN »

NEW YORK, NY, USA (June 23, 2020) — During the height of the COVID-19 pandemic in New York City, health care workers on the front lines had high levels of acute stress, anxiety, and depression, a study by researchers at Columbia University Irving Medical Center and NewYork-Presbyterian has found. Levels of stress, anxiety and depression
WEITERLESEN »

  South Australia, Australia (June 20, 2020) — A novel formulation of the prostate cancer drug abiraterone acetate – currently marketed as Zytiga – will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials by the University of South Australia show the new formulation improves the drug’s effectiveness by
WEITERLESEN »

  Better quality of life for people with rheumatic and musculoskeletal diseases   Kilchberg, Switzerland (June 17, 2020) — Disease-related, profound fatigue impairs the quality of life of many people with rheumatic and musculoskeletal diseases. A Belgian study (1) has now concluded that early intensive treatment combining methotrexate with a bridging scheme of prednisone can
WEITERLESEN »

Coronavirus could be transmitted through a long-lasting cloud of virus-containing aerosol droplets ejected from a flushing toilet. WASHINGTON, USA (June 16, 2020) — Researchers used a computer simulation to show how a flushing toilet can create a cloud of virus-containing aerosol droplets that is large and widespread and lasts long enough that the droplets could
WEITERLESEN »

WEST LAFAYETTE, Ind., USA (June 16, 2020) — Conventional melanoma therapies, including chemotherapy and radiotherapy, suffer from the toxicity and side effects of repeated treatments due to the aggressive and recurrent nature of melanoma cells. Less invasive topical chemotherapies have emerged as alternatives, but their widespread uses have been hindered by both the painful size
WEITERLESEN »

  Nijmegen, Netherlands (June 12, 2020) — Silicone molecules from breast implants can initiate processes in human cells that lead to cell death. Researchers from Radboud University have demonstrated this in a new study that will be published on 12 June in Scientific Reports. „However, there are still many questions about what this could mean
WEITERLESEN »

Our sleep during lockdown: Longer and more regular, but worse   Basel, Switzerland (June 12, 2020) — Research assumes that many sleep disorders are caused by our modern lifestyle, which is characterized by pressure to constantly perform and be active. Rhythms of work and leisure activities thus set a cycle that is often at a
WEITERLESEN »

  Isotope measurements on air filters: researchers investigated undeclared nuclear   Münster, Germany (June 12, 2020) — A mysterious cloud containing radioactive ruthenium-106, which moved across Europe in autumn 2017, is still bothering Europe’s radiation protection entities. Although the activity concentrations were innocuous, they reached up to 100 times the levels of what had been
WEITERLESEN »

  London, UK (June 12, 2020) — Emerging evidence suggests that COVID-19 may actually trigger the onset of diabetes in healthy people and also cause severe complications of pre-existing diabetes. A letter published today in the New England Journal of Medicine and signed by an international group of 17 leading diabetes experts involved in the
WEITERLESEN »

  Boston, MA, USA (June 12, 2020) — During the COVID-19 pandemic, patients with multiple sclerosis (MS) and their clinicians have had questions and concerns about whether immunotherapies for MS could influence risk for infection or lead to an unfavorable outcome. In the Journal of Neurology, Rohit Bakshi, MD, a senior neurologist at Brigham and
WEITERLESEN »

  Test that relies on viral genetic material gives false negative if uded too early on those infected   Baltimore, MA, USA (June 10, 2020) — In a new study, Johns Hopkins researchers found that testing people for SARS-CoV-2 — the virus that causes COVID-19 — too early in the course of infection is likely
WEITERLESEN »

  Persistently engaging in negative thinking patterns may raise the risk of Alzheimer’s disease, finds a new UCL-led study   London, UK (June 7, 2020) — In the study of people aged over 55, published in Alzheimer’s & Dementia, researchers found ‚repetitive negative thinking‘ (RNT) is linked to subsequent cognitive decline as well as the
WEITERLESEN »

  (June 5, 2020) — A new paper published online in the Annals of the American Thoracic Society examines ventilation and medication strategies that can help avoid psychological trauma for severe COVID-19 survivors treated for acute respiratory distress syndrome (ARDS) with mechanical ventilation. In „Air Hunger and Psychological Trauma in Ventilated COVID-19 Patients: An Urgent
WEITERLESEN »

  Dr. Maria Jose Soler Romeo talked about the Spanish COVID-19 Dialysis/Transplantation Experience at the Opening Conference of the ERA-EDTA Congress   (June 5, 2020) — Spain is one of the European countries besides the UK and Italy that was particularly hard hit by the coronavirus pandemic in March. Early on, it was not possible
WEITERLESEN »

  New York, NY, USA (March 27, 2020) — In a new study, researchers found that half of the patients they treated for mild COVID-19 infection still had coronavirus for up to eight days after symptoms disappeared. The research letter was published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care
WEITERLESEN »

Ozanimod is the latest in a series of novel medicines to originate from the laboratories of Scripps Research LA JOLLA, CA, USA (March 26, 2020) — The U.S. Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis. The drug
WEITERLESEN »

  Houston, Texas, USA (March 26,2020) — Shortages of respiratory protective devices for healthcare personnel are major concerns during the COVID-19 pandemic. A team of researchers at Baylor College of Medicine, Emory University, the University of Texas Health Science Center at Houston and the National Institute for Occupational Safety and Health Centers at the Centers
WEITERLESEN »

Engineers at Stanford describe potential transmission pathways of COVID-19 and their implications Stanford, California, USA (March 26, 2020) — Much remains unknown about how SARS-CoV-2, the virus that causes COVID-19, spreads through the environment. A major reason for this is that the behaviors and traits of viruses are highly variable – some spread more easily
WEITERLESEN »

  New York, NY, USA (March 26, 2020) — Columbia Mailman School of Public Health’s Dr. John W. Rowe, Professor of Health Policy and Aging, is a member of a WHO Expert Panel on Care of the Elderly which just released the attached guidance for prevention and management of COVID-19 among elderly in long term
WEITERLESEN »

COVID-19 Beware of falsified medicines from unregistered websites   Amsterdam, The Netherlands (March 24, 2020) — EMA is urging the general public not to buy medicines from unauthorised websites and other vendors aiming to exploit fears and concerns during the ongoing pandemic of coronavirus disease (COVID-19). Vendors may claim that their products can treat or
WEITERLESEN »